OptimiseRx™ is First to Provide Medicines Optimisation Support to Five NHS CCGs

OptimiseRxHearst Health International announced that OptimiseRx has become the first solution to be procured by a federation of five London Clinical Commissioning Groups (CCGs) under a new procurement framework from NHS Shared Business Services (NHS SBS). The appointment was announced by Simon Radcliffe, Head of UK Commercial Management, Hearst Health International.

More than 220 GP practices across North West London are now benefiting from OptimiseRx, patient-specific medicines optimisation software under a new prescribing decision support procurement framework from NHS SBS. NHS Central London, Ealing, Hammersmith and Fulham, Hounslow and West London CCGs have selected OptimiseRx as the solution of choice to enable better prescribing decision support through patient-specific care guidance.

"We wanted a solution that would enable our CCG to provide GPs with clinical information before a prescribing decision is made - which is why we selected OptimiseRx because of its ability to provide highly targeted guidance at the right time in the GP or prescriber's workflow" said Dr Tony Willis, Diabetes and IT Clinical Lead for Hammersmith and Fulham CCG. "Whilst reducing our prescribing spend is critical, our local medicines management agenda is all about improving clinical outcomes for our patients. Having a medicines optimisation solution that helps target specific patients based on clinical parameters in the GP record is crucial to us to, both to avoid overloading prescribers with inappropriate information and to improve prescribing safety."

Thomas Slater, Strategic Procurement Lead at NHS SBS commented, "This is a great example of a real NHS collaboration that will help the wider NHS make significant savings on an important technology needed across the country. The five CCGs with whom we have worked with are already reaping the benefits of supplier choice. Our newly launched framework allows the wider NHS to achieve best price, terms and wider market choice in the same way, without the need to conduct their own time consuming and expensive competitions."

OptimiseRx works by providing guidance messages within the GPs prescribing workflow. The messages are evidence-based and tailored to the individual patient record within EMIS Web and TPP SystmOne, enabling GPs to make optimal prescribing decisions that are clinically appropriate and cost-effective for the patient in consultation.

"We have seen an enormous shift in the requirements of CCGs and prescribing teams recently" Radcliffe said. "Purely switching to cheaper prescriptions is no longer a viable option; CCGs tell us that they want to support GPs to make prescribing decisions that are clinically appropriate and support in-year savings against prescribing budgets, too. The five CCGs across North West London are representative of the trend towards more outcome-based prescribing and we are delighted to be able to provide a solution to enable them to make more clinically appropriate and more cost-effective prescribing decisions."

OptimiseRx can now be procured through the Medicines Management Prescribing Decision Support Systems Framework (MMDSS).

About OptimiseRx
OptimiseRx is the UK's only medicines optimisation solution within primary care that provides prescribing decision support that is tailored to the individual patient medical record, ensuring that all recommendations presented to GPs are patient-specific.

OptimiseRx from First Databank Europe, is part of Hearst Health International's network of care guidance solutions.

About Hearst Health International
FDB (First Databank), Map of Medicine, Zynx Health and MCG comprise the Hearst Health network. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey.

With over 100 people based in the UK, our team comprises both depth and diversity of industry knowledge and expertise including medical doctors, registered nurses, pharmacists and health informaticists, dedicated to serving the NHS. We have more than 30 years' experience of developing and implementing clinical decision support solutions with around 180 customers across CCGs, secondary care and community Trusts, as well as a significant number of community pharmacies and mental health Trusts.

About Hearst
Hearst is one of the nation's largest diversified media, information and services companies with more than 360 businesses. Its major interests include ownership in cable television networks such as A&E, HISTORY, Lifetime and ESPN; majority ownership of global ratings agency Fitch Group; Hearst Health, a group of medical information and services businesses; 30 television stations such as WCVB-TV in Boston and KCRA-TV in Sacramento, Calif., which reach a combined 19 percent of U.S. viewers; newspapers such as the Houston Chronicle, San Francisco Chronicle and Albany Times Union, more than 300 magazines around the world including Cosmopolitan, ELLE, Harper’s BAZAAR and Car and Driver; digital services businesses such as iCrossing and KUBRA; and investments in emerging digital and video companies such as BuzzFeed, VICE and AwesomenessTV.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...